Skip to Main Content

Paper Details

Allogeneic double-negative T cell therapy for relapsed acute myeloid leukemia patients post allogeneic hematopoietic stem cell transplantation: A first-in-human phase I study.
Am J Hematol
3
2022
Author NameAffiliation
Aaron D SchimmerPrincess Margaret Cancer Centre, University Health Network
  • 1 - 1

Datasets

Release 1.2